Fusobacterium nucleatum promotes inflammatory and anti-apoptotic responses in colorectal cancer cells via ADP-heptose release and ALPK1/TIFA axis activation

References

• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–19. doi:10.3322/caac.21492.
   PubMed Web of Science ®Google Scholar
• Ananthakrishnan AN, Bernstein CN, Iliopoulos D, Macpherson A, Neurath MF, Ali RAR, Vavricka SR, Fiocchi C. Environmental triggers in IBD: a review of progress and evidence. Nat Rev Gastro Hepat. 2018;15(1):39–49. doi:10.1038/nrgastro.2017.136.
   PubMed Web of Science ®Google Scholar
• Thomas AM, Manghi P, Asnicar F, Pasolli E, Armanini F, Zolfo M, Beghini F, Manara S, Karcher N, Pozzi C, et al. Metagenomic analysis of colorectal cancer datasets identifies cross-cohort microbial diagnostic signatures and a link with choline degradation. Nat Med. 2019;25(4):667–678. doi:10.1038/s41591-019-0405-7.
   PubMed Web of Science ®Google Scholar
• Wirbel J, Pyl PT, Kartal E, Zych K, Kashani A, Milanese A, Fleck JS, Voigt AY, Palleja A, Ponnudurai R, et al. Meta-analysis of fecal metagenomes reveals global microbial signatures that are specific for colorectal cancer. Nat Med. 2019;25(4):679–689. doi:10.1038/s41591-019-0406-6.
   PubMed Web of Science ®Google Scholar
• Allali I, Delgado S, Marron PI, Astudillo A, Yeh JJ, Ghazal H, Amzazi S, Keku T, Azcarate-Peril MA. Gut microbiome compositional and functional differences between tumor and non-tumor adjacent tissues from cohorts from the US and Spain. Gut Microbes. 2015;6(3):161–72. doi:10.1080/19490976.2015.1039223.
   PubMed Web of Science ®Google Scholar
• Repass J, Maherali N, Owen K. Reproducibility Project: Cancer B, Reproducibility Project Cancer B. Registered report: Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Elife. 2016;5. doi:10.7554/eLife.10012.
   PubMed Web of Science ®Google Scholar
• Repass J, Iorns E, Denis A, Williams SR, Perfito N, Errington TM. Reproducibility Project: Cancer B. Replication Study: Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Elife. 2018;7. doi:10.7554/eLife.25801.
   PubMed Web of Science ®Google Scholar
• Kostic AD, Chun E, Robertson L, Glickman JN, Gallini CA, Michaud M, Clancy T, Chung D, Lochhead P, Hold G, et al. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe. 2013;14(2):207–215. doi:10.1016/j.chom.2013.07.007.
   PubMed Web of Science ®Google Scholar
• Castellarin M, Warren RL, Freeman JD, Dreolini L, Krzywinski M, Strauss J, Barnes R, Watson P, Allen-Vercoe E, Moore RA, et al. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res. 2012;22(2):299–306. doi:10.1101/gr.126516.111.
   PubMed Web of Science ®Google Scholar
• Kostic AD, Gevers D, Pedamallu CS, Michaud M, Duke F, Earl AM, Ojesina AI, Jung J, Bass AJ, Tabernero J, et al. Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome Res. 2012;22(2):292–298. doi:10.1101/gr.126573.111.
   PubMed Web of Science ®Google Scholar
• Feng Q, Liang S, Jia H, Stadlmayr A, Tang L, Lan Z, Zhang D, Xia H, Xu X, Jie Z, et al. Gut microbiome development along the colorectal adenoma–carcinoma sequence. Nat Commun. 2015;6(1):6528. doi:10.1038/ncomms7528.
   PubMed Web of Science ®Google Scholar
• Zeller G, Tap J, Voigt AY, Sunagawa S, Kultima JR, Costea PI, Amiot A, Böhm J, Brunetti F, Habermann N, et al. Potential of fecal microbiota for early-stage detection of colorectal cancer. Mol Syst Biol. 2014;10(11):766. doi:10.15252/msb.20145645.
   PubMed Web of Science ®Google Scholar
• Nakatsu G, Li X, Zhou H, Sheng J, Wong SH, Wu WK, Ng SC, Tsoi H, Dong Y, Zhang N, et al. Gut mucosal microbiome across stages of colorectal carcinogenesis. Nat Commun. 2015;6(1):8727. doi:10.1038/ncomms9727.
   PubMed Web of Science ®Google Scholar
• Ito M, Kanno S, Nosho K, Sukawa Y, Mitsuhashi K, Kurihara H, Igarashi H, Takahashi T, Tachibana M, Takahashi H, et al. Association of Fusobacterium nucleatum with clinical and molecular features in colorectal serrated pathway. Int J Cancer. 2015;137(6):1258–1268. doi:10.1002/ijc.29488.
   PubMed Web of Science ®Google Scholar
• Yu J, Chen Y, Fu X, Zhou X, Peng Y, Shi L, Chen T, Wu Y. Invasive Fusobacterium nucleatum may play a role in the carcinogenesis of proximal colon cancer through the serrated neoplasia pathway. Int J Cancer. 2016;139(6):1318–26. doi:10.1002/ijc.30168.
   PubMed Web of Science ®Google Scholar
• Dai Z, Coker OO, Nakatsu G, WKK W, Zhao L, Chen Z, Chan FKL, Kristiansen K, Sung JJY, Wong SH, et al. Multi-cohort analysis of colorectal cancer metagenome identified altered bacteria across populations and universal bacterial markers. Microbiome. 2018;6(1):70. doi:10.1186/s40168-018-0451-2.
   PubMed Web of Science ®Google Scholar
• Young C, Wood HM, Seshadri RA, Van Nang P, Vaccaro C, Melendez LC, Bose M, Van Doi M, Piñero TA, Valladares CT, et al. The colorectal cancer-associated faecal microbiome of developing countries resembles that of developed countries. Genome Med. 2021;13(1):27. doi:10.1186/s13073-021-00844-8.
   PubMed Web of Science ®Google Scholar
• Yu T, Guo F, Yu Y, Sun T, Ma D, Han J, Qian Y, Kryczek I, Sun D, Nagarsheth N, et al. Fusobacterium nucleatum promotes chemoresistance to colorectal cancer by modulating autophagy. Cell. 2017;170(3):548–63 e16. doi:10.1016/j.cell.2017.07.008.
   PubMed Web of Science ®Google Scholar
• Zhang S, Yang Y, Weng W, Guo B, Cai G, Ma Y, Cai S. Fusobacterium nucleatum promotes chemoresistance to 5-fluorouracil by upregulation of BIRC3 expression in colorectal cancer. J Exp Clin Cancer Res. 2019;38(1):14. doi:10.1186/s13046-018-0985-y.
   PubMedGoogle Scholar
• Abed J, Emgard JE, Zamir G, Faroja M, Almogy G, Grenov A, Sol A, Naor R, Pikarsky E, Atlan KA. Fap2 Mediates Fusobacterium nucleatum Colorectal Adenocarcinoma Enrichment by Binding to Tumor-Expressed Gal-GalNAc. Cell Host Microbe. 2016;20:215–225. doi:10.1016/j.chom.2016.07.006.
   PubMed Web of Science ®Google Scholar
• Rubinstein MR, Wang X, Liu W, Hao Y, Cai G, Han YW. Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/beta-catenin signaling via its FadA adhesin. Cell Host Microbe. 2013;14:195–206. doi:10.1016/j.chom.2013.07.012.
   PubMed Web of Science ®Google Scholar
• Guo P, Tian Z, Kong X, Yang L, Shan X, Dong B, Ding X, Jing X, Jiang C, Jiang N, et al. FadA promotes DNA damage and progression of Fusobacterium nucleatum-induced colorectal cancer through up-regulation of chk2. J Exp Clin Cancer Res. 2020;39(1):202. doi:10.1186/s13046-020-01677-w.
   PubMed Web of Science ®Google Scholar
• Gur C, Ibrahim Y, Isaacson B, Yamin R, Abed J, Gamliel M, Enk J, Bar-On Y, Stanietsky-Kaynan N, Coppenhagen-Glazer S, et al. Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack. Immunity. 2015;42(2):344–355. doi:10.1016/j.immuni.2015.01.010.
   PubMed Web of Science ®Google Scholar
• Yang Y, Weng W, Peng J, Hong L, Yang L, Toiyama Y, Gao R, Liu M, Yin M, Pan C, et al. Fusobacterium nucleatum increases proliferation of colorectal cancer cells and tumor development in mice by activating toll-like receptor 4 signaling to nuclear Factor−κB, and up-regulating expression of MicroRNA-21. Gastroenterology. 2017;152(4):851–66 e24. doi:10.1053/j.gastro.2016.11.018.
   PubMed Web of Science ®Google Scholar
• Tilg H, Adolph TE, Gerner RR, Moschen AR. The intestinal microbiota in colorectal cancer. Cancer Cell. 2018;33(6):954–964. doi:10.1016/j.ccell.2018.03.004.
   PubMed Web of Science ®Google Scholar
• Couturier-Maillard A, Secher T, Rehman A, Normand S, De Arcangelis A, Haesler R, Huot L, Grandjean T, Bressenot A, Delanoye-Crespin A, et al. NOD2-mediated dysbiosis predisposes mice to transmissible colitis and colorectal cancer. J Clin Invest. 2013;123:700–711. doi:10.1172/JCI62236.
   PubMed Web of Science ®Google Scholar
• Chen R, Alvero AB, Silasi DA, Steffensen KD, Mor G. Cancers take their toll—the function and regulation of toll-like receptors in cancer cells. Oncogene. 2008;27(2):225–33. doi:10.1038/sj.onc.1210907.
   PubMed Web of Science ®Google Scholar
• Garcia-Weber D, Dangeard AS, Cornil J, Thai L, Rytter H, Zamyatina A, Mulard LA, Arrieumerlou C. ADP-heptose is a newly identified pathogen-associated molecular pattern of shigella flexneri. EMBO Rep. 2018;19(12). doi:10.15252/embr.201846943.
   PubMed Web of Science ®Google Scholar
• Zhou P, She Y, Dong N, Li P, He H, Borio A, Wu Q, Lu S, Ding X, Cao Y, et al. Alpha-kinase 1 is a cytosolic innate immune receptor for bacterial ADP-heptose. Nature. 2018;561(7721):122–126. doi:10.1038/s41586-018-0433-3.
   PubMed Web of Science ®Google Scholar
• Milivojevic M, Dangeard AS, Kasper CA, Tschon T, Emmenlauer M, Pique C, Schnupf P, Guignot J, Arrieumerlou C, et al. ALPK1 controls TIFA/TRAF6-dependent innate immunity against heptose-1,7-bisphosphate of gram-negative bacteria. PLoS Pathog. 2017;13(2):e1006224. doi:10.1371/journal.ppat.1006224.
   PubMed Web of Science ®Google Scholar
• Martin-Gallausiaux C, Garcia-Weber D, Lashermes A, Larraufie P, Marinelli L, Teixeira V, Rolland A, Béguet-Crespel F, Brochard V, Quatremare T, et al. Akkermansia muciniphila upregulates genes involved in maintaining the intestinal barrier function via ADP-heptose-dependent activation of the ALPK1/TIFA pathway. Gut Microbes. 2022;14(1):2110639. doi:10.1080/19490976.2022.2110639.
   PubMed Web of Science ®Google Scholar
• Gaudet RG, Guo CX, Molinaro R, Kottwitz H, Rohde JR, Dangeard AS, Arrieumerlou C, Girardin SE, Gray-Owen SD. Innate recognition of intracellular bacterial growth is driven by the TIFA-Dependent cytosolic surveillance pathway. Cell Rep. 2017;19(7):1418–30. doi:10.1016/j.celrep.2017.04.063.
   PubMed Web of Science ®Google Scholar
• Cui J, Duizer C, Bouwman LI, van Rooijen KS, Voogdt CGP, van Putten JPM, de Zoete MR. The ALPK1 pathway drives the inflammatory response to Campylobacter jejuni in human intestinal epithelial cells. PLoS Pathog. 2021;17(8):e1009787. doi:10.1371/journal.ppat.1009787.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhang L, Zheng S, Li M, Xu C, Jia D, Qi Y, Hou T, Wang L, Wang B, et al. Fusobacterium nucleatum promotes colorectal cancer cells adhesion to endothelial cells and facilitates extravasation and metastasis by inducing ALPK1/NF-κB/ICAM1 axis. Gut Microbes. 2022;14(1):2038852. doi:10.1080/19490976.2022.2038852.
   PubMed Web of Science ®Google Scholar
• Ryzhakov G, West NR, Franchini F, Clare S, Ilott NE, Sansom SN, Bullers SJ, Pearson C, Costain A, Vaughan-Jackson A, et al. Alpha kinase 1 controls intestinal inflammation by suppressing the IL-12/Th1 axis. Nat Commun. 2018;9(1):3797. doi:10.1038/s41467-018-06085-5.
   PubMed Web of Science ®Google Scholar
• Strietz J, Stepputtis SS, Preca BT, Vannier C, Kim MM, Castro DJ, Au Q, Boerries M, Busch H, Aza-Blanc P, et al. ERN1 and ALPK1 inhibit differentiation of bi-potential tumor-initiating cells in human breast cancer. Oncotarget. 2016;7(50):83278–83293. doi:10.18632/oncotarget.13086.
   PubMedGoogle Scholar
• Liao HF, Lee HH, Chang YS, Lin CL, Liu TY, Chen YC, Yen J-C, Lee Y-T, Lin C-Y, Wu S-H, et al. Down-regulated and commonly mutated ALPK1 in lung and colorectal cancers. Sci Rep. 2016;6(1):27350. doi:10.1038/srep27350.
   PubMedGoogle Scholar
• Chen PK, Hua CH, Hsu HT, Kuo TM, Chung CM, Lee CP, Tsai M-H, Yeh K-T, Ko Y-C. ALPK1 expression is associated with lymph node metastasis and tumor growth in oral squamous cell carcinoma patients. Am J Pathol. 2019;189(1):190–9. doi:10.1016/j.ajpath.2018.09.003.
   PubMed Web of Science ®Google Scholar
• Sangiorgi E, Azzara A, Molinario C, Pietrobono R, Rigante D, Verrecchia E, Sicignano LL, Genuardi M, Gurrieri F, Manna R, et al. Rare missense variants in the ALPK1 gene may predispose to periodic fever, aphthous stomatitis, pharyngitis and adenitis (PFAPA) syndrome. Eur J Hum Genet. 2019;27(9):1361–1368. doi:10.1038/s41431-019-0421-6.
   PubMed Web of Science ®Google Scholar
• Rashid M, van der Horst M, Mentzel T, Butera F, Ferreira I, Pance A, Rütten A, Luzar B, Marusic Z, de Saint Aubain N, et al. ALPK1 hotspot mutation as a driver of human spiradenoma and spiradenocarcinoma. Nat Commun. 2019;10(1):2213. doi:10.1038/s41467-019-09979-0.
   PubMedGoogle Scholar
• Wei TW, Wu PY, Wu TJ, Hou HA, Chou WC, Teng CJ, Lin C-R, Chen JMM, Lin T-Y, Su H-C, et al. Aurora a and NF-κB survival pathway drive chemoresistance in acute myeloid leukemia via the TRAF-Interacting protein TIFA. Cancer Res. 2017;77(2):494–508. doi:10.1158/0008-5472.CAN-16-1004.
   PubMed Web of Science ®Google Scholar
• Bauer M, Nascakova Z, Mihai AI, Cheng PF, Levesque MP, Lampart S, Hurwitz R, Pfannkuch L, Dobrovolna J, Jacobs M, et al. The ALPK1/TIFA/NF-κB axis links a bacterial carcinogen to R-loop-induced replication stress. Nat Commun. 2020;11(1):5117. doi:10.1038/s41467-020-18857-z.
   PubMed Web of Science ®Google Scholar
• Wang FF, Zhao PY, He XJ, Jiang K, Wang TS, Xiao JW, Sun D-B, Guo D-H. Fusobacterium necrophorum promotes apoptosis and inflammatory cytokine production through the activation of NF-κB and death receptor signaling pathways. Front Cell Infect Microbiol. 2022;12:827750. doi:10.3389/fcimb.2022.827750.
   PubMed Web of Science ®Google Scholar
• Martin-Gallausiaux C, Malabirade A, Habier J, Wilmes P. Fusobacterium nucleatum extracellular vesicles modulate Gut epithelial cell innate immunity via FomA and TLR2. Front Immunol. 2020;11:583644. doi:10.3389/fimmu.2020.583644.
   PubMed Web of Science ®Google Scholar
• Chen Y, Peng Y, Yu J, Chen T, Wu Y, Shi L, Li Q, Wu J, Fu X. Invasive Fusobacterium nucleatum activates beta-catenin signaling in colorectal cancer via a TLR4/P-PAK1 cascade. Oncotarget. 2017;8(19):31802–14. doi:10.18632/oncotarget.15992.
   PubMedGoogle Scholar
• Nomoto D, Baba Y, Liu Y, Tsutsuki H, Okadome K, Harada K, Ishimoto T, Iwatsuki M, Iwagami S, Miyamoto Y, et al. Fusobacterium nucleatum promotes esophageal squamous cell carcinoma progression via the NOD1/RIPK2/NF-κB pathway. Cancer Lett. 2022;530:59–67. doi:10.1016/j.canlet.2022.01.014.
   PubMed Web of Science ®Google Scholar
• Alyami HM, Finoti LS, Teixeira HS, Aljefri A, Kinane DF, Benakanakere MR. Role of NOD1/NOD2 receptors in Fusobacterium nucleatum mediated NETosis. Microb Pathog. 2019;131:53–64. doi:10.1016/j.micpath.2019.03.036.
   PubMed Web of Science ®Google Scholar
• Barnich N, Aguirre JE, Reinecker HC, Xavier R, Podolsky DK. Membrane recruitment of NOD2 in intestinal epithelial cells is essential for nuclear factor–κB activation in muramyl dipeptide recognition. J Cell Biol. 2005;170(1):21–6. doi:10.1083/jcb.200502153.
   PubMed Web of Science ®Google Scholar
• Pfannkuch L, Hurwitz R, Traulsen J, Sigulla J, Poeschke M, Matzner L, Kosma P, Schmid M, Meyer TF. ADP heptose, a novel pathogen-associated molecular pattern identified in Helicobacter pylori. FASEB J. 2019;33(8):9087–99. doi:10.1096/fj.201802555R.
   PubMed Web of Science ®Google Scholar
• Marinelli L, Martin-Gallausiaux C, Bourhis J, Beguet-Crespel F, Blottiere HM, Lapaque N. Identification of the novel role of butyrate as AhR ligand in human intestinal epithelial cells. Sci Rep. 2019;9(1):643. doi:10.1038/s41598-018-37019-2.
   PubMedGoogle Scholar
• Martin-Gallausiaux C, Beguet-Crespel F, Marinelli L, Jamet A, Ledue F, Blottiere HM, Lapaque N. Butyrate produced by gut commensal bacteria activates TGF-beta1 expression through the transcription factor SP1 in human intestinal epithelial cells. Sci Rep. 2018;8(1):9742. doi:10.1038/s41598-018-28048-y.
   PubMed Web of Science ®Google Scholar
• Martin-Gallausiaux C, Larraufie P, Jarry A, Beguet-Crespel F, Marinelli L, Ledue F, Reimann F, Blottière HM, Lapaque N. Butyrate produced by commensal bacteria down-regulates indolamine 2,3-dioxygenase 1 (IDO-1) expression via a dual mechanism in human intestinal epithelial cells. Front Immunol. 2018;9:2838. doi:10.3389/fimmu.2018.02838.
   PubMed Web of Science ®Google Scholar
• Leung CH, Lam W, Ma DL, Gullen EA, Cheng YC. Butyrate mediates nucleotide-binding and oligomerisation domain (NOD) 2-dependent mucosal immune responses against peptidoglycan. Eur J Immunol. 2009;39(12):3529–3537. doi:10.1002/eji.200939454.
   PubMed Web of Science ®Google Scholar
• Lakhdari O, Tap J, Beguet-Crespel F, Le Roux K, de Wouters T, Cultrone A, Nepelska M, Lefèvre F, Doré J, Blottière HM. Identification of NF-κB modulation capabilities within human intestinal commensal bacteria. J Biomed Biotechnol. 2011;2011:1–9. doi:10.1155/2011/282356.
   Google Scholar
• Larraufie P, Dore J, Lapaque N, Blottiere HM. TLR ligands and butyrate increase pyy expression through two distinct but inter-regulated pathways. Cell Microbiol. 2016;19(2):e12648. doi:10.1111/cmi.12648.
   Web of Science ®Google Scholar
• Lucas C, Barnich N, Nguyen NH. Microbiota, Inflammation and Colorectal Cancer. Int J Mol Sci. 2017;18(6):18. doi:10.3390/ijms18061310.
   Web of Science ®Google Scholar
• Thomas AM, Fidelle M, Routy B, Kroemer G, Wargo JA, Segata N, Zitvogel L. Gut OncoMicrobiome signatures (GOMS) as next-generation biomarkers for cancer immunotherapy. Nat Rev Clin Oncol. 2023;20(9):583–603. doi:10.1038/s41571-023-00785-8.
   PubMed Web of Science ®Google Scholar
• Yeoh YK, Chen Z, Wong MCS, Hui M, Yu J, Ng SC, Sung JJY, Chan FKL, Chan PKS. Southern Chinese populations harbour non-nucleatum fusobacteria possessing homologues of the colorectal cancer-associated FadA virulence factor. Gut. 2020;69(11):1998–2007. doi:10.1136/gutjnl-2019-319635.
   PubMed Web of Science ®Google Scholar
• Gaudet RG, Sintsova A, Buckwalter CM, Leung N, Cochrane A, Li J, Cox AD, Moffat J, Gray-Owen SD. INNATE IMMUNITY. Cytosolic detection of the bacterial metabolite HBP activates TIFA-dependent innate immunity. Sci. 2015;348(6240):1251–5. doi:10.1126/science.aaa4921.
   PubMed Web of Science ®Google Scholar
• Taniguchi K, Karin M. NF-κB, inflammation, immunity and cancer: coming of age. Nat Rev Immunol. 2018;18(5):309–24. doi:10.1038/nri.2017.142.
   PubMed Web of Science ®Google Scholar
• Bazzichetto C, Milella M, Zampiva I, Simionato F, Amoreo CA, Buglioni S, Pacelli C, Le Pera L, Colombo T, Bria E, et al. Interleukin-8 in colorectal cancer: a systematic review and meta-analysis of its potential role as a prognostic biomarker. Biomedicines. 2022;10(10). doi:10.3390/biomedicines10102631.
   PubMed Web of Science ®Google Scholar
• Casasanta MA, Yoo CC, Udayasuryan B, Sanders BE, Umana A, Zhang Y, Peng H, Duncan AJ, Wang Y, Li L, et al. Fusobacterium nucleatum host-cell binding and invasion induces IL-8 and CXCL1 secretion that drives colorectal cancer cell migration. Sci Signal. 2020;13(641). doi:10.1126/scisignal.aba9157.
   PubMed Web of Science ®Google Scholar
• Qiu Z, Wang Y, Zhang Z, Qin R, Peng Y, Tang W, Xi Y, Tian G, Zhang Y. Roles of intercellular cell adhesion molecule-1 (ICAM-1) in colorectal cancer: expression, functions, prognosis, tumorigenesis, polymorphisms and therapeutic implications. Front Oncol. 2022;12:1052672. doi:10.3389/fonc.2022.1052672.
   PubMed Web of Science ®Google Scholar
• Vereecke L, Vieira-Silva S, Billiet T, van Es JH, Mc Guire C, Slowicka K, Sze M, van den Born M, De Hertogh G, Clevers H, et al. A20 controls intestinal homeostasis through cell-specific activities. Nat Commun. 2014;5(1):5103. doi:10.1038/ncomms6103.
   PubMedGoogle Scholar
• Dagenais M, Dupaul-Chicoine J, Champagne C, Skeldon A, Morizot A, Saleh M. A critical role for cellular inhibitor of protein 2 (cIAP2) in colitis-associated colorectal cancer and intestinal homeostasis mediated by the inflammasome and survival pathways. Mucosal Immunol. 2016;9(1):146–158. doi:10.1038/mi.2015.46.
   PubMed Web of Science ®Google Scholar
• Levy J, Cacheux W, Bara MA, L’Hermitte A, Lepage P, Fraudeau M, Trentesaux C, Lemarchand J, Durand A, Crain A-M, et al. Intestinal inhibition of Atg7 prevents tumour initiation through a microbiome-influenced immune response and suppresses tumour growth. Nat Cell Biol. 2015;17(8):1062–1073. doi:10.1038/ncb3206.
   PubMed Web of Science ®Google Scholar
• Geng F, Zhang Y, Lu Z, Zhang S, Pan Y. Fusobacterium nucleatum caused DNA damage and promoted cell proliferation by the Ku70/p53 pathway in oral cancer cells. DNA Cell Biol. 2020;39(1):144–51. doi:10.1089/dna.2019.5064.
   PubMed Web of Science ®Google Scholar
• Sayed IM, Chakraborty A, Abd El-Hafeez AA, Sharma A, Sahan AZ, Huang WJM, Sahoo D, Ghosh P, Hazra TK, Das S, et al. The DNA glycosylase NEIL2 suppresses Fusobacterium-infection-induced inflammation and DNA damage in colonic epithelial cells. Cells. 2020;9(9):1980. doi:10.3390/cells9091980.
   PubMed Web of Science ®Google Scholar
• Okita Y, Koi M, Takeda K, Ross R, Mukherjee B, Koeppe E, Stoffel EM, Galanko JA, McCoy AN, Keku TO, et al. Fusobacterium nucleatum infection correlates with two types of microsatellite alterations in colorectal cancer and triggers DNA damage. Gut Pathog. 2020;12(1):46. doi:10.1186/s13099-020-00384-3.
   PubMed Web of Science ®Google Scholar
• Nejman D, Livyatan I, Fuks G, Gavert N, Zwang Y, Geller LT, Rotter-Maskowitz A, Weiser R, Mallel G, Gigi E, et al. The human tumor microbiome is composed of tumor type–specific intracellular bacteria. Sci. 2020;368(6494):973–80. doi:10.1126/science.aay9189.
   PubMed Web of Science ®Google Scholar
• Ko AM, Tu HP, Ko YC. Systematic review of the role of Alpha-protein kinase 1 in cancer and cancer-related inflammatory diseases. Cancers Basel. 2022;14(18):14. doi:10.3390/cancers14184390.
   Web of Science ®Google Scholar
• Lakhdari O, Cultrone A, Tap J, Gloux K, Bernard F, Ehrlich SD, Lefèvre F, Doré J, Blottière HM, et al. Correction: functional metagenomics: a High throughput screening method to decipher microbiota-Driven NF-κB modulation in the human Gut. PLoS ONE. 2010;5(10). doi:10.1371/annotation/9f1b7f00-bcc0-4442-9775-491ebdafc7bc.
   PubMedGoogle Scholar
• Hungate RE. The anaerobic mesophilic cellulolytic bacteria. Bacteriol Rev. 1950;14(1):1–49. doi:10.1128/br.14.1.1-49.1950.
   PubMedGoogle Scholar
• Baba T, Ara T, Hasegawa M, Takai Y, Okumura Y, Baba M, Datsenko KA, Tomita M, Wanner BL, Mori H, et al. Construction of Escherichia coli K-12 in-frame, single-gene knockout mutants: the Keio collection. Mol Syst Biol. 2006;2(1):2006–0008. doi:10.1038/msb4100050.
   Google Scholar